
Overview
Pharmacy Solutions operates the Apteki 4 Pory Roku brand and its Partner Pharmacy Network, which has supported pharmacies across Poland for 15 years. The company supplies pharmacies with products at attractive prices and works with leading drug manufacturers. It is part of the Investcare Pharmaceutical Group and runs health campaigns, including on diabetes and obesity.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 32 days early.
- 202524/06/2026
- 202410/07/2025
- 202303/07/2024
- 202202/06/2023
- 202101/07/2022
- 202008/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

15 years together with you: Agnieszka Kobus-Małanecz

15 years together with you: The history of a pharmacy that connects generations

15 years together with you: One of the first pharmacies

15 years together with you: Anna Szwed

15 years together with you: Grzegorz Snopczyński

15 years together with you: Natalia Piotrowska
Industry
Offer
- Medicinal products for pharmacies
- Support for partner pharmacies
- Pharmaceutical care
- Workshops for pharmacists
Websites
- apteka4poryroku.plApteki 4 Pory RokuWordPress 6.6ElementorGoogle AnalyticsGoogle Tag ManagerLLiteSpeed
Trademarks
The company holds 7 active trademarks registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2010.
| Mark | Protected until | |
|---|---|---|
| MEDICARE APTEKA | Aug 19, 2035 | |
| 4 PORY ROKU APTEKA | Jul 18, 2032 | |
| 4 PORY ROKU | Jul 18, 2032 | |
| APTEKA 4 PORY ROKU | Jul 18, 2032 | |
| Pharmacy Solutions | Oct 10, 2028 |
Job offers
The company has its own careers page: apteka4poryroku.pl/kariera.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company is represented by the member of the management board independently, or by two commercial proxies jointly. In the case of a multi-member management board, the company is represented by two members of the management board jointly or by one member of the management board jointly with a commercial proxy, or by two commercial proxies jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 8,336 | $112,587.79 | 68.8926% | |
Adam Pecyna age 50 | 1,882 | $25,418.69 | 15.5537% |
Tomasz Płonka age 45 | 1,882 | $25,418.69 | 15.5537% |
The articles of association require approval of the remaining shareholders for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Biocanto Pharma sp. z o.o. | 32,414.91 USD | 16.6667% | ||
Miropharm sp. z o.o. | 136,399.24 USD | 99.9901% | ||
Ipharm 5 sp. z o.o. | 41,329.01 USD | 51% |
Capital group
The company belongs to the Investcare (Poland) group, which is its direct owner.
Bank accounts
Registered as a VAT taxpayer on 2011-02-23.
57 1140 1049 0000 4237 3700 1001
11 1050 1214 1000 0090 3098 3150
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $77,230.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $5,260$5,260 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $60,448$60,448 | Polski Fundusz Rozwoju S.A. | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $6,431$6,431 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Hurtownia Farmaceutyczna Bieńkowski sp. j. | $22,704,222.23 | bienkowski.czest.pl | ||
| UNIT Dose Pharma sp. z o.o. | $13,712,927.12 | udpharma.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-Kielce S.A. | $13,590,657.96 | farmacol.com.pl | ||
| Orion Pharma Poland sp. z o.o. | $13,123,658.19 | orionpharma.pl | ||
| Interpharma sp. z o.o. | $12,321,125.25 | interpharma.com.pl | ||
| Ewopharma Ag sp. z o.o. | $9,500,844.61 | ewopharma.pl | ||
| Solpharm sp. z o.o. | $6,142,616.88 | solpharm.pl | ||
| Ekspres Apteczny sp. z o.o. | $2,671,602.33 | ekspresapteczny.pl | ||
| Hurtownia Farmaceutyczna Solinea sp. z o.o. | $2,622,347.04 | solinea.pl | ||
| Biocanto sp. z o.o. | $1,951,967.77 | biocanto.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-10-16 | Address change (Aleja Niepodległości 106, 43-100, Tychy → Ul. Białobrzeska 45, 41-409, Mysłowice) | |
| 2015-09-11 | PKD change (Removed: 21 codes; Added: 1 code) | |
| 2014-03-26 | PKD change (Added: 13 codes) | |
| 2013-10-10 | Address change (Białobrzeska 45, 41-409, Mysłowice → Aleja Niepodległości 106, 43-100, Tychy) | |
| 2011-11-18 | Share capital increase (5,000.00 PLN → 605,000.00 PLN) |
FAQ
Last updated: 2026-06-24